[1] Tang C,Lan C,Wang C,Liu R. Alleviation of multiple organ dysfunction syndrome by somatostatin via suppression of intestinal mucosal mast cells. Shock 2005( accepted)
[2] Tang C, Liu C, Zhou X,et al.Enhanced inhibitive Effect of combination of rofecoxib and octreotide on the growth of human gastric cancer. Int J Cancer, 2004,112(3)
[3] Tang CW, Lan C, Liu R. Increased activity of the intestinal mucosal mast cells in rats with multiple organ failure . Chin J Dig Dis, 2004;5(2)
[4] Tang C, Wang C, Tang L. Effects of combined octreotide and aspirin on the growth of gastric cancer. Chin Med J (Engl),2003,116(3)
[5] Wang C,Tang C.Inhibitory effect of octreotide on gastric cancer growth via MAPK pathway.World J Gastroenterol, 2003,9(9)
[6] Tang C ,Zhao X ,Han J. Primary culture of porcine pancreatic acinar cells. PANCREAS,2002;25(1)
[7] Tang C, el at.Visualization and Characterization of Receptors for Vasoactive Intestinal Peptide and Secretin in Colon Neoplasms. Chin J Cancer Research, 2001,13(4)
[8] Tang C, el at.Expression of somatostatin receptors in human pancreatic tumor. Pancreas, 1998,17:80-84
[9] Tang C, el at.Development of regulatory peptide receptors in the pancreata of rats. Int J Pancreatol,1998,23:276
[10] Tang C, el at.Expression of peptide receptors in human endocrine tumors of the pancreas. Gut 1997;40:267-271
[11] Tang C, el at.Visualization and characterization of CCK receptor in exocrine pancreas of rat with storage phosphor autoradiography. Pancreas, 1996,13,311-315
[12] Tang C, el at.Gut peptide receptors in pancreata of BOP-treated and normal control hamsters. Carcinogenesis 1996;17:2171-2175
[13] Tang C, el at.Cholecystokinin receptors in human pancreas and gallbladder muscle: A comparative study. Gastroenterology 1996,111:1621-1626